ArticleJournal of gastrointestinal cancer2026

KRAS Mutation Status as a Prognostic Marker and Predictor of Therapy Response in Colorectal Cancer: an NCDB Analysis.

Mohyeddine El Sayed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.